Appointment booking for Dr. Joseph Biundo, MD is currently not available.Dr. Joseph Biundo, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Joseph Biundo, MD (he/him) is a Rheumatologist in Metairie, LA with over 18 years of experience. What is your opinion of Dr. Joseph Biundo, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Joseph Biundo, MD has received over $10,295 which includes payments from the following companies:
$2,516.36 from Merck Sharp & Dohme Corporation
$1,371.22 from AbbVie, Inc.
$1,207.48 from Amgen Inc.
$485.27 from Celgene Corporation
$444.22 from E.R. Squibb & Sons, L.L.C.
$415.25 from Pfizer Inc.
$394.22 from West-Ward Pharmaceuticals
$386.72 from Horizon Pharma plc
$343.60 from UCB, Inc.
$341.69 from Genentech USA, Inc.
$339.13 from Regeneron Healthcare Solutions, Inc.
$248.04 from Janssen Biotech, Inc.
$244.78 from GlaxoSmithKline, LLC.
$224.79 from Mallinckrodt LLC
$172.31 from LILLY USA, LLC
$169.81 from Novartis Pharmaceuticals Corporation
$142.31 from Ironwood Pharmaceuticals, Inc
$106.34 from Daiichi Sankyo Inc.
$99.05 from Takeda Pharmaceuticals America, Inc.
$91.48 from Depomed, Inc.
Payments received by Dr. Joseph Biundo, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!